From the Food and Drug Administration: FDA Approves First Biologic to Treat Rare Clotting Disorder, 3/30 FDA Announces Discontinued Marketing of GI Drug, Zelnorm, for Safety Rea, 3/30 FDA Announces Voluntary Withdrawal of Pergolide Products, 3/29 From the Maryland Department ...
Read More »BPW approves $1.1B deal for new prescription drug plan
ANNAPOLIS - The Board of Public Works approved a $1.1 billion contract Wednesday for a new prescription drug plan for state employees, after a company CEO assured...
Read More »Harassing calls from office spur suit against company
A Middle River woman who was the victim of dozens of harassing telephone calls placed from a Raymond James Financial Services Inc. office has filed a multimillion-dollar lawsuit against the two convicted callers and the company.
Read More »Pfizer wins rejection of generic drug challenge to Lipitor patent
Pfizer Inc. fought off a U.S. Supreme Court appeal that aimed to open the company
Read More »Cancer victim's kin sue Kaiser
The family of a man who died of lung cancer has charged in a lawsuit that doctors at the Kaiser Permanente managed-care firm let eight months elapse between taking and reading a chest X-ray that showed a spot on his lung.
Read More »P.G. County, state at odds over hospital
ANNAPOLIS - With financial and legislative deadlines looming, Prince George
Read More »Longer Wait, Hotter Oven Make Pizza Crust Healthier
<p>Hungry as pizza eaters often are, they might be wise to wait a few minutes longer for a healthier whole-wheat crust, according to a study.
Read More »Bills to limit in vitro egg donation stall in both chambers
Legislative proposals that would ban egg donation for in vitro fertilization or stem cell research in Maryland have stalled this year in their respective committees.
Read More »HealthSouth sells surgery business to private group for $920M cash and stake in business
BIRMINGHAM, Ala. - Rehabilitation chain HealthSouth Corp. said Monday it has agreed to sell its surgery division for about $920 million in cash plus a stake in the surgery business, its second major divestiture this year as it restructures after a major financial scandal.
Read More »Senate defeats moves to curb Medicare costs
WASHINGTON - The Senate easily defeated conservative Republicans' efforts to curb the Medicare program's spiraling growth as debate on a $2.9 trillion budget outline for 2008...
Read More »